Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Hydrogels show promise in preventing and treating skin damage from radiation therapy.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Shiunko ointment may help prevent scalp dermatitis during radiotherapy but doesn't stop hair loss.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Topical tofacitinib is effective and safe for treating alopecia areata.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Abnormal contraction of connective tissue in hair follicles causes hair loss by killing off important cells, and treating this could improve hair growth.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Transglutaminase 2 may control sebocyte maturation and lipid metabolism.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Researchers found that certain RNA circles in the brain are linked to disease risk, but their exact role in disease is still unknown.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

The Journal of Cutaneous and Aesthetic Surgery is now included in PubMed.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.